Drugs / ProAlgaZyme
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00518960 | Apr → Sep 2007 | hyperlipidemia, metabolic syndrome X | Health Enhancement Products, Inc. | Unknown | No outcome recorded |
| — | NCT00489333 | May → Sep 2006 | metabolic syndrome X | Health Enhancement Products, Inc. | Completed | No outcome recorded |
| — | NCT00493506 | May → Sep 2006 | HIV infectious disease, hepatitis B virus infection, hyperlipidemia | Health Enhancement Products, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ProAlgaZyme | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00489333 ↗ |
| Modality | Other / unclassified | “a novel fermentation product of a freshwater algae ecosystem” NCT00493506 ↗ |
| Route | Oral | “four daily oral doses (1 fl oz) of ProAlgaZyme” PMID 17803818 ↗ Sep 2007 |